Clinical Trials

1. Clinical predictors of treatment failure for diabetic foot infections: data from a prospective trial.

Author
Lipsky BA; Sheehan P; Armstrong DG; Tice AD; Polis AB; Abramson MA;
Institution
Veterans Affairs Puget Sound Health Care System, University of Washington School of Medicine, Seattle, WA 98108-1597, USA. benjamin.lipsiy@med.va.gov
Journal
Int Wound J. 2007 Mar;4(1):30-8.
Abstract URL
Click here to view abstract

2. Negative pressure wound therapy via vacuum-assisted closure following partial foot amputation: what is the role of wound chronicity?

Author
Armstrong DG; Lavery LA; Boulton AJ;
Institution
Scholl's Center for Lower Extremity Ambulatory Research, Rosalind Franklin University of Medicine and Science, North Chicago, IL 60064, USA. armstrong@usa.net
Journal
Int Wound J. 2007 Mar;4(1):79-86.
Abstract URL
Click here to view abstract

3. An off-the-shelf instant contact casting device for the management of diabetic foot ulcers: a randomized prospective trial versus traditional fiberglass cast.

Author
Piaggesi A; Macchiarini S; Rizzo L; Palumbo F; Tedeschi A; Nobili LA; Leporati E; Scire V; Teobaldi I; Del Prato S;
Institution
Section of Diabetes and Metabolic Diseases, Department of Endocrinology and Metabolism, University of Pisa and Azienda Ospedaliera Pisana, Pisa, Italy. piaggesi@immr.med.unipi.it
Journal
Diabetes Care. 2007 Mar;30(3):586-90.
Abstract URL
Click here to view abstract

4. Thrombin peptide Chrysalin stimulates healing of diabetic foot ulcers in a placebo-controlled phase I/II study.

Author
Fife C; Mader JT; Stone J; Brill L; Satterfield K; Norfleet A; Zwernemann A; Ryaby JT; Carney DH;
Institution
Department of Anesthesiology, University of Texas Health Science Center, Houston, Texas 77555-0645, USA.
Journal
Wound Repair Regen. 2007 Jan-Feb;15(1):23-34.
Abstract URL
Click here to view abstract

5. Does dermal thermometry predict clinical outcome in diabetic foot infection? Analysis of data from the SIDESTEP* trial.

Author
Armstrong DG; Lipsky BA; Polis AB; Abramson MA;
Institution
Rosalind Franklin University, Chicago, IL, USA. Armstrong@usa.net
Journal
Int Wound J. 2006 Dec;3(4):302-7.
Abstract URL
Click here to view abstract

6. Preventing diabetic foot ulcer recurrence in high-risk patients: use of temperature monitoring as a self-assessment tool.

Author
Lavery LA; Higgins KR; Lanctot DR; Constantinides GP; Zamorano RG; Athanasiou KA; Armstrong DG; Agrawal CM;
Institution
Department of Surgery, Scott and White Hospital, Texas A&M University Health Science Center, Temple, Texas, USA. llavery@swmail.org
Journal
Diabetes Care. 2007 Jan;30(1):14-20.
Abstract URL
Click here to view abstract

7. Talactoferrin alfa, a recombinant human lactoferrin promotes healing of diabetic neuropathic ulcers: a phase 1/2 clinical study.

Author
Lyons TE; Miller MS; Serena T; Sheehan P; Lavery L; Kirsner RS; Armstrong DG; Reese A; Yankee EW; Veves A; Lyons TE; Miller MS; Serena T; Sheehan P; Lavery L; Kirsner RS; Armstrong DG; Reese A; Yankee EW; Veves A;
Institution
Beth Israel Deaconess Medical Center and Harvard Medical School, Palmer 321 A, West Campus, Boston, MA 02215, USA.
Journal
Am J Surg. 2007 Jan;193(1):49-54.
Abstract URL
Click here to view abstract

8. Larval therapy: a novel treatment in eliminating methicillin-resistant Staphylococcus aureus from diabetic foot ulcers.

Author
Bowling FL; Salgami EV; Boulton AJ;
Institution
University Department of Medicine and Diabetes, Manchester Royal Infirmary, Oxford Road, Manchester M13 9WL, U.K. frank.bowling@manchester.ac.uk
Journal
Diabetes Care. 2007 Feb;30(2):370-1.

9. Prospective randomized controlled study of Hydrofiber dressing containing ionic silver or calcium alginate dressings in non-ischaemic diabetic foot ulcers.

Author
Jude EB; Apelqvist J; Spraul M; Martini J;
Institution
Department of Diabetic Medicine, Tameside General Hospital, Ashton-Under-Lyne, UK. edward.jude@tgh.nhs.uk
Journal
Diabet Med. 2007 Mar;24(3):280-8.
Abstract URL
Click here to view abstract

10. Evaluation of Bensal HP for the treatment of diabetic foot ulcers.

Author
Jacobs AM; Tomczak R;
Institution
Caribbean Medical University, Piscadera Bay, Curacao, Netherlands Antilles.
Journal
Adv Skin Wound Care. 2008 Oct;21(10):461-5.
Abstract URL
Click here to view abstract

11. Intermittent intravenous urokinase for critical limb ischemia in diabetic foot ulceration.

Author
Weck M; Rietzsch H; Lawall H; Pichlmeier U; Bramlage P; Schellong S;
Institution
Clinic Bavaria, Dept. Diabetes, Metabolism and Endocrinology, Kreischa, Germany.
Journal
Thromb Haemost. 2008 Sep;100(3):475-82.
Abstract URL
Click here to view abstract

12. Education for secondary prevention of foot ulcers in people with diabetes: a randomised controlled trial.

Author
Lincoln NB; Radford KA; Game FL; Jeffcoate WJ;
Institution
Institute of Work, Health and Organisations, University of Nottingham, Nottingham, UK.
Journal
Diabetologia. 2008 Nov;51(11):1954-61. Epub 2008 Aug 30.
Abstract URL
Click here to view abstract

13. The influence of local versus global heat on the healing of chronic wounds in patients with diabetes.

Author
Petrofsky JS; Lawson D; Suh HJ; Rossi C; Zapata K; Broadwell E; Littleton L;
Institution
Department of Physical Therapy, School of Allied Health Professions, Loma Linda University, Loma Linda, California 92350, USA. jpetrofsky@llu.edu
Journal
Diabetes Technol Ther. 2007 Dec;9(6):535-44.
Abstract URL
Click here to view abstract

14. Wound healing: total contact cast vs. custom-made temporary footwear for patients with diabetic foot ulceration.

Author
Van De Weg FB; Van Der Windt DA; Vahl AC;
Institution
Rehabilitation Centre Amsterdam, Amsterdam, The Netherlands. f.b.vandeweg@olvg.nl
Journal
Prosthet Orthot Int. 2008 Mar;32(1):3-11.
Abstract URL
Click here to view abstract

15. Randomized, controlled, single-blind study on use of autologous keratinocytes on a transfer dressing to treat nonhealing diabetic ulcers.

Author
Moustafa M; Bullock AJ; Creagh FM; Heller S; Jeffcoate W; Game F; Amery C; Tesfaye S; Ince Z; Haddow DB; MacNeil S;
Institution
Northern General Hospital, Division of Clinical Sciences (North), School of Medicine, Sheffield, S5 7AU, UK.
Journal
Regen Med. 2007 Nov;2(6):887-902.
Abstract URL
Click here to view abstract

16. Unsuspected osteomyelitis is frequent in persistent diabetic foot ulcer and better diagnosed by MRI than by 18F-FDG PET or 99mTc-MOAB.

Author
Schwegler B; Stumpe KD; Weishaupt D; Strobel K; Spinas GA; von Schulthess GK; Hodler J; Boni T; Donath MY;
Institution
Clinic for Endocrinology and Diabetes, University Hospital, Zurich, Switzerland.
Journal
J Intern Med. 2008 Jan;263(1):99-106. Epub 2007 Nov 23.
Abstract URL
Click here to view abstract

17. Phase I trial on the safety of topical rhVEGF on chronic neuropathic diabetic foot ulcers.

Author
Hanft JR; Pollak RA; Barbul A; van Gils C; Kwon PS; Gray SM; Lynch CJ; Semba CP; Breen TJ;
Institution
Doctor's Research Network, South Miami, Florida, USA.
Journal
J Wound Care. 2008 Jan;17(1):30-2, 34-7.
Abstract URL
Click here to view abstract

18. The football: an intuitive dressing for offloading neuropathic plantar forefoot ulcerations.

Author
Rader AJ; Barry TP;
Institution
Memorial Hospital and Healthcare Center, The Wound Care Center St Mary's Healthcare Center, Diabetic Foot Clinic, Jasper, IN 47546, USA. pvppc@fullnet.com
Journal
Int Wound J. 2008 Mar;5(1):69-73. Epub 2008 Jan 3.
Abstract URL
Click here to view abstract

19. Skin temperature monitoring reduces the risk for diabetic foot ulceration in high-risk patients.

Author
Armstrong DG; Holtz-Neiderer K; Wendel C; Mohler MJ; Kimbriel HR; Lavery LA;
Institution
Scholl's Center for Lower Extremity Ambulatory Research (CLEAR), Rosalind Franklin University of Medicine and Science, North Chicago, Ill 60064, USA. armstrong@usa.net
Journal
Am J Med. 2007 Dec;120(12):1042-6.
Abstract URL
Click here to view abstract

20. Phagocytic activity of neutrophils improves over the course of therapy of diabetic foot infections.

Author
Top C; Yildiz S; Oncul O; Qydedi T; Cevikbas A; Soyogul UG; Cavuslu S;
Institution
Department of Internal Medicine, Gulhane Military Medical Academy, GATA Haydarpasa Training Hospital, Tibbiye Cad. 81327 Haydarpasa, Istanbul, Turkey. tpcihan@hotmail.com
Journal
J Infect. 2007 Oct;55(4):369-73. Epub 2007 Aug 2.
Abstract URL
Click here to view abstract

21. Risk of plantar ulceration in diabetic patients with single-leg amputation.

Author
Kanade RV; van Deursen RW; Price P; Harding K;
Institution
Research Centre for Clinical Kinaesiology, Department of Physiotherapy, School of Healthcare Studies, Cardiff University, Ty Dewi Sant, Health Park, Cardiff CF14 4XN, United Kingdom.
Journal
Clin Biomech (Bristol, Avon). 2006 Mar;21(3):306-13. Epub 2005 Nov 28.
Abstract URL
Click here to view abstract

22. Effectiveness of recombinant human platelet-derived growth factor for the treatment of diabetic neuropathic foot ulcers.

Author
Margolis DJ; Bartus C; Hoffstad O; Malay S; Berlin JA;
Institution
Department of Dermatology, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 19104, USA. dmargoli@cceb.med.upenn.edu
Journal
Wound Repair Regen. 2005 Nov-Dec;13(6):531-6.
Abstract URL
Click here to view abstract

23. Ultrasound therapy for recalcitrant diabetic foot ulcers: results of a randomized, double-blind, controlled, multicenter study.

Author
Ennis WJ; Foremann P; Mozen N; Massey J; Conner-Kerr T; Meneses P;
Institution
Wound Treatment Program, Advocate Christ Medical Center, 4440 West 95th Street, Oak Lawn, IL 60453, USA. wtc211@pol.net
Journal
Ostomy Wound Manage. 2005 Aug;51(8):24-39.
Abstract URL
Click here to view abstract

24. Quality of life and clinical correlates in patients with diabetic foot ulcers.

Author
Valensi P; Girod I; Baron F; Moreau-Defarges T; Guillon P;
Institution
Department of Endocrinology-Diabetology-Nutrition, Jean Verdier Hospital, Paris-Nord University, Bondy, France. paul.valensi@jvr.ap-hop-paris.fr
Journal
Diabetes Metab. 2005 Jun;31(3 Pt 1):263-71.
Abstract URL
Click here to view abstract

25. Recombinant human epidermal growth factor (EGF) to enhance healing for diabetic foot ulcers.

Author
Hong JP; Jung HD; Kim YW;
Institution
Department of Plastic and Reconstructive Surgery, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea. joonphong@amc.seoul.kr
Journal
Ann Plast Surg. 2006 Apr;56(4):394-8; discussion 399-400.
Abstract URL
Click here to view abstract

26. Effect of window casts on healing rates of diabetic foot ulcers.

Author
Agas CM; Bui TD; Driver VR; Gordon IL;
Institution
VA Long Beach Healthcare System, Department of Vascular Surgery, California, USA.
Journal
J Wound Care. 2006 Feb;15(2):80-3.

27. Sustained silver-releasing dressing in the treatment of diabetic foot ulcers.

Author
Rayman G; Rayman A; Baker NR; Jurgeviciene N; Dargis V; Sulcaite R; Pantelejeva O; Harding KG; Price P; Lohmann M; Thomsen JK; Gad P; Gottrup F;
Institution
Diabetic Foot Research Office, The Ipswich Hospital NHS Trust, Ipswich UK.
Journal
Br J Nurs. 2005 Jan 27-Feb 9;14(2):109-14.
Abstract URL
Click here to view abstract

28. A randomized trial of two irremovable off-loading devices in the management of plantar neuropathic diabetic foot ulcers.

Author
Katz IA; Harlan A; Miranda-Palma B; Prieto-Sanchez L; Armstrong DG; Bowker JH; Mizel MS; Boulton AJ;
Institution
Division of Endocrinology, Diabetes and Metabolism, Department of Medicine, University of Miami, DRI Building, 1450 N.W. 10th Ave., Room 3054, P.O. Box 016960 (D110), Miami, FL 33101, USA. irakatz@bellsouth.net
Journal
Diabetes Care. 2005 Mar;28(3):555-9.
Abstract URL
Click here to view abstract

29. Healing diabetic neuropathic foot ulcers: are we getting better?

Author
Margolis DJ; Allen-Taylor L; Hoffstad O; Berlin JA;
Institution
Department of Dermatology, University of Pennsylvania School of Medicine, Philadelphia, PA 19104, USA. dmargoli@cceb.med.upenn.edu
Journal
Diabet Med. 2005 Feb;22(2):172-6.
Abstract URL
Click here to view abstract

30. An open-label, randomized study comparing efficacy and safety of intravenous piperacillin/tazobactam and ampicillin/sulbactam for infected diabetic foot ulcers.

Author
Harkless L; Boghossian J; Pollak R; Caputo W; Dana A; Gray S; Wu D;
Institution
University of Texas Health Science Center, UCCH/Texas Diabetes Institute, San Antonio, Texas, USA.
Journal
Surg Infect (Larchmt). 2005 Spring;6(1):27-40.
Abstract URL
Click here to view abstract

31. Health-related quality of life of diabetic foot ulcer patients and their caregivers.

Author
Nabuurs-Franssen MH; Huijberts MS; Nieuwenhuijzen Kruseman AC; Willems J; Schaper NC;
Institution
Division of Endocrinology, Department of Internal Medicine, University Hospital Maastricht, PO Box 5800, 6202 AZ Maastricht, The Netherlands. marrigje.nabuurs@gmail.com
Journal
Diabetologia. 2005 Sep;48(9):1906-10. Epub 2005 Jul 2.
Abstract URL
Click here to view abstract

32. Diabetic neuropathic foot ulcers and amputation.

Author
Margolis DJ; Allen-Taylor L; Hoffstad O; Berlin JA;
Institution
Department of Dermatology, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 19104, USA. dmargoli@cceb.med.upenn.edu
Journal
Wound Repair Regen. 2005 May-Jun;13(3):230-6.
Abstract URL
Click here to view abstract

33. Can the use of a topical antifungal nail lacquer reduce risk for diabetic foot ulceration? Results from a randomised controlled pilot study.

Author
Armstrong DG; Holtz K; Wu S;
Institution
Scholl's Center for Lower Extremity Ambulatory Research (CLEAR) at Rosalind Franklin University of Medicine, 3333 Green Bay Road, Chicago, IL 60064, USA. armstrong@usa.net
Journal
Int Wound J. 2005 Jun;2(2):166-70.
Abstract URL
Click here to view abstract

34. A prospective, randomized, controlled trial of autologous platelet-rich plasma gel for the treatment of diabetic foot ulcers.

Author
Driver VR; Hanft J; Fylling CP; Beriou JM; Autologel Diabetic Foot Ulcer Study Group;
Institution
Cytomedix, Inc., 416 Hungerford Drive, Rockville, MD 20850, USA.
Journal
Ostomy Wound Manage. 2006 Jun;52(6):68-70, 72, 74 passim.
Abstract URL
Click here to view abstract